Pharmaceuticals

Bisoprolol Market Forecast to Reach $3.26 Billion by 2030 at 8.5% CAGR

March 18, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Bisoprolol Market Evolve From 2026 To 2030?

The bisoprolol market has experienced robust expansion over the past few years. Forecasts indicate its size will increase from $2.17 billion in 2025 to $2.35 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. This historical expansion is primarily due to factors such as the significant occurrence of hypertension, the proven clinical effectiveness of beta-blockers, an aging demographic, the rise in hospital-based cardiac services, and widespread prescriptions by physicians.

The bisoprolol market is projected to experience substantial expansion over the coming years, reaching $3.26 billion by 2030, with a compound annual growth rate (CAGR) of 8.5%. This anticipated growth during the forecast period is driven by factors such as the increasing burden of cardiovascular diseases, improved accessibility to generic medications, the rise of outpatient cardiac care, the broadening of pharmacy networks, and enhanced programs promoting treatment adherence. Key trends anticipated within this period include the escalating prevalence of cardiovascular disorders, the expanding application of beta-blockers in chronic care settings, a greater uptake of generic cardiovascular drugs, the growth of both retail and hospital pharmacies, and an intensified emphasis on sustained blood pressure management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18977&type=smp

What Drivers Are Influencing The Bisoprolol Market?

The expanding occurrence of hypertension is anticipated to fuel the expansion of the bisoprolol market in the future. Hypertension is defined as a health condition marked by blood pressure levels that are persistently higher than the typical physiological range. The rise in hypertension’s prevalence can be attributed to inactive lifestyles and growing rates of obesity. The bisoprolol market aids in managing hypertension by reducing blood pressure, decreasing the heart’s workload, and enhancing blood circulation. For example, data from February 2024, provided by the Singapore Ministry of Health, a government health authority in Singapore, showed that the prevalence of hypertension among adults reached 36.1% in 2023, an increase from 33.0% in 2022, signifying a notable year-over-year rise. Consequently, the growing prevalence of hypertension is a key factor boosting the expansion of the bisoprolol market.

Which Segment Areas Are Covered In The Bisoprolol Market Analysis?

The bisoprolol market covered in this report is segmented –

1) By Type: Tablet, Capsule

2) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

3) By Application: High Blood Pressure, Coronary Heart Disease, Angina Pectoris, Other Applications

Subsegments:

1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets

2) By Capsule: Immediate-Release Capsules, Extended-Release Capsules, Hard Gelatin Capsules

What Key Developments And Trends Are Impacting The Bisoprolol Market?

Leading companies in the bisoprolol market are concentrating on developing innovative solutions, including fixed-dose combinations and extended-release formulations, to improve patient compliance, enhance cardiovascular outcomes, and address shortcomings of traditional treatments. Fixed-dose combinations are medications that merge two or more active drugs into a single pill to streamline therapy, while extended-release formulations are engineered to gradually release the drug over time for longer-lasting effects and reduced dosing frequency. For example, in June 2025, Cadila Pharmaceuticals Limited, an India-based pharmaceutical company, launched Biscado (Bisoprolol) in India, marking its entry into the beta-blocker therapy segment for managing cardiovascular diseases. This product is a highly cardioselective beta-1 adrenergic blocker prescribed for treating high blood pressure, angina, and chronic heart failure by decreasing heart rate and blood pressure to reduce stress on the heart. It is clinically supported by studies showing significant reductions in mortality, sudden cardiac death, and hospitalizations for heart failure. Biscado is available as a once-daily dose and in fixed-dose combinations with other antihypertensive agents, aligning with global cardiovascular treatment guidelines and improving patient adherence in India.

Which Global Companies Are Actively Competing In The Bisoprolol Market?

Major companies operating in the bisoprolol market are Merck & Co. Inc., Abbott Healthcare Pvt Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Aurobindo Pharma Limited, Intas Pharmaceuticals Limited, Cipla Limited, Hikma Pharmaceuticals, Lupin Limited, Dr. Reddy’s Laboratories Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Ipca Laboratories Limited, Medreich Limited, Alembic Pharmaceuticals Limited, Accord Healthcare Limited, Zydus Lifesciences Limited, Zentiva Group, Taj Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Suanfarma, Rusan Healthcare Limited, VHB Lifesciences Limited, Synnat Pharmaceuticals, Vidakem Lifesciences Pvt Ltd, Pluviaendo Pharmaceuticals

Read the full bisoprolol market report here:

https://www.thebusinessresearchcompany.com/report/bisoprolol-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Bisoprolol Market?

North America was the largest region in the bisoprolol market in 2025. The regions covered in the bisoprolol market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bisoprolol Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18977&type=smp

Browse Through More Reports Similar to the Global Bisoprolol Market 2026, By The Business Research Company

Metoprolol Tartrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/metoprolol-tartrate-global-market-report

Bi Specific Mab Market Report 2026

https://www.thebusinessresearchcompany.com/report/bi-specific-mab-global-market-report

Clopidogrel Market Report 2026

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795